Market Tracker

10/20 5:16pm ET

Quest Diagnostics Inc (NYSE:DGX)

95.08
Delayed Data
As of Oct 20
 +1.85 / +1.98%
Today’s Change
79.12
Today|||52-Week Range
112.97
+3.46%
Year-to-Date
Quest Diagnostics (DGX) Beats Earnings in Q3, Updates View
Oct 19 / Zacks.com - Paid Partner Content
Bernard Horn Comments on Quest Diagnostics
Oct 18 / GuruFocus News - Paid Partner Content
Quest Diagnostics (DGX) Tops Q3 Earnings, Revenues In Line
Oct 19 / Zacks.com - Paid Partner Content
Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?
Oct 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close93.23
Today’s open93.61
Day’s range93.55 - 95.29
Volume1,806,762
Average volume (3 months)1,053,488
Market cap$12.7B
Dividend yield1.89%
Data as of 4:02pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-7.16%
Earnings growth (this year)+9.42%
Earnings growth (next 5 years)+7.26%
Revenue growth (last year)+0.29%
P/E ratio19.2
Price/Sales1.74
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
LHLaboratory Corporati...+0.40+0.26%
FMIFoundation Medicine ...-0.55-1.32%
GHDXGenomic Health Inc-0.14-0.41%
KANGiKang Healthcare Gro...+0.06+0.45%
Data as of 4:02pm ET, 10/20/2017

Financials

Last reporting dateOctober 19, 2017
EPS forecast (this quarter)$1.37
Annual revenue (last year)$7.5B
Annual profit (last year)$642.0M
Net profit margin8.54%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chairman, President &
Chief Executive Officer
Stephen H. Rusckowski
Chief Financial Officer &
Senior Vice President
Mark J. Guinan
Corporate headquarters
Secaucus, New Jersey

Forecasts